title: [Intravenous furosemide during renal scintigraphy with TC-99M DTPA].
authors.forename: J B
authors.initials: JB
authors.lastname: Palcoux
authors.forename: J
authors.initials: J
authors.lastname: Bonafous
authors.forename: P
authors.initials: P
authors.lastname: Vanlieferinghen
authors.forename: A
authors.initials: A
authors.lastname: Veyre
authors.forename: V
authors.initials: V
authors.lastname: Desvignes
authors.forename: P
authors.initials: P
authors.lastname: Martin
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D005665:Furosemide / Q000008:administration & dosage; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007668:Kidney / Q000000981:diagnostic imaging*; D008297:Male; D009942:Organometallic Compounds; D004369:Pentetic Acid; D011877:Radionuclide Imaging; D016284:Technetium Tc 99m Pentetate; D014570:Urologic Diseases / Q000000981:diagnostic imaging*
chemical_list: D009942:Organometallic Compounds; D004369:Pentetic Acid; D005665:Furosemide; D016284:Technetium Tc 99m Pentetate
vernacular_title: Furosémide intraveineux au cours de la scintigraphie rénale au 99mTc-DTPA.